SCREENING OF LIPID PROFILE IN NON- OBESE HYPERTENSIVE SUBJECTS AT A TERTIARY CARE HOSPITAL IN BIHAR | Asian Journal of Advances in Medical Science
Obesity in adults is a substantial risk factor for metabolic syndrome. Even in normoglycaemic, non-hypertensive people, central fat distribution affects the lipid profile and causes atherogenic dyslipidemia.
As a result, the current study's goal is to investigate lipid profile changes in non-obese hypertension participants. Obesity, hypertension, and dyslipidemia are three major risk factors for a lipid profile that is out of whack. Obesity is defined as an excessive accumulation of body fat caused by a persistent or periodic positive energy balance in which energy intake exceeds energy expenditure [1]. Overweight indicators can help in the diagnosis and treatment of obesity in both children and adults.
Materials and Methods: This study focused on newly diagnosed cases of essential hypertension who visited the M.G.M. Medical College, Kisanganj, medical outdoor. To rule out any systemic or other disorders that could alter blood lipid levels directly or indirectly, a thorough clinical examination, including laboratory testing, was performed.
The link between dyslipidemia, obesity, and hypertension is well documented, and all three have been identified as key risk factors for the development of CAD, which is a main cause of physician visits and death.
Conclusion: We conducted this study to determine the influence of obesity on lipid profile profile in hypertension patients exclusively, not the general population, and we discovered some distinct but contradictory consequences. These include that in obesity with hypertension, total and LDL cholesterol, as well as HDL cholesterol, are reduced, but the value of VLDL cholesterol and triglycerides, on the other hand, is grossly and dramatically elevated. These findings have two major clinical implications: obese hypertensives are more likely to develop metabolic syndrome and type 2 diabetes mellitus, and steps should be taken to prevent these conditions. In addition to statins, obese hypertensives should be treated with fibrates, fat restriction, and physical activity.
Please see the link:- http://mbimph.com/index.php/AJOAIMS/article/view/2041
